e.g. mhealth
Search Results (1 to 5 of 5 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 2 JMIR Formative Research
- 1 JMIR Human Factors
- 1 JMIR Research Protocols
- 1 Journal of Medical Internet Research
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Medical Informatics
- 0 JMIR Public Health and Surveillance
- 0 JMIR mHealth and uHealth
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
Go back to the top of the page Skip and go to footer section
Patient Engagement in a Multimodal Digital Phenotyping Study of Opioid Use Disorder
The opioid crisis continues unabated in the United States, with 2.7 million individuals diagnosed with past-year opioid use disorder (OUD) in 2020 [1] and over 100,000 fatal overdoses from opioids in the 12 months ending in May 2022 [2]. Buprenorphine is an effective medication for treating OUD, reducing opioid use, and lowering mortality risk; yet, many do not remain in treatment, and the risk of relapse is high [3-6].
J Med Internet Res 2023;25:e45556
Download Citation: END BibTex RIS
Epidemiological occupational health studies indicated that high physical and stressful job demands were strongly associated with OUD [18,20-23]. Therefore, combining on-the-job risk factors for injury coupled with provider prescription recommendations for opioid use could elevate the risk of developing OUD within these occupational groups [1].
JMIR Form Res 2023;7:e45434
Download Citation: END BibTex RIS
Due to the many historical accessibility barriers associated with obtaining a DEA-X waiver, only about 5% of physicians in the United States have acquired this prescriptive authority, which, in turn, limits the ability to care for patients with opioid use disorder (OUD) [2]. Get Waivered (GW) was founded to address this caveat by encouraging and facilitating more clinicians in obtaining their DEA-X waiver.
JMIR Hum Factors 2023;10:e40244
Download Citation: END BibTex RIS
Unprecedented rates of opioid misuse and mortality have led to the current opioid epidemic in the United States [1], with approximately 2.5 million people in the United States meeting the criteria for opioid use disorder (OUD) in 2020 [2]. OUD is a chronic condition with numerous physical, psychological, and personal consequences, including a high risk of death, which has risen in recent years due to the increasing prevalence of potent synthetic opioids (predominantly fentanyl) [3].
JMIR Res Protoc 2023;12:e43122
Download Citation: END BibTex RIS